Search tips
Search criteria 


Logo of narLink to Publisher's site
Nucleic Acids Res. 1986 March 11; 14(5): 2408.
PMCID: PMC339667

Antithrombin III tours gene: identification of a point mutation leading to an arginine----cysteine replacement in a silent deficiency.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (96K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Chasse JF, Esnard F, Guitton JD, Mouray H, Perigois F, Fauconneau G, Gauthier F. An abnormal plasma antithrombin with no apparent affinity for heparin. Thromb Res. 1984 May 15;34(4):297–302. [PubMed]
  • Huynh-Dinh T, Duchange N, Zakin MM, Lemarchand A, Igolen J. Modified oligonucleotides as alternatives to the synthesis of mixed probes for the screening of cDNA libraries. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7510–7514. [PubMed]
  • Prochownik EV, Markham AF, Orkin SH. Isolation of a cDNA clone for human antithrombin III. J Biol Chem. 1983 Jul 10;258(13):8389–8394. [PubMed]
  • Koide T, Odani S, Takahashi K, Ono T, Sakuragawa N. Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability. Proc Natl Acad Sci U S A. 1984 Jan;81(2):289–293. [PubMed]
  • Sakuragawa N, Takahashi K, Kondo S, Koide T. Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis. Thromb Res. 1983 Jul 15;31(2):305–317. [PubMed]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press